Clinical Trial Update: First-line Replacement Maintenance of Envafolimab in Advanced NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating first-line replacement maintenance with Envafolimab in advanced non-small cell lung cancer (NSCLC) is ongoing, with the status curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN